NCT02732392View on ClinicalTrials.gov

Validation of Radioisotope Guided Lymphadenectomy for Loco-regional Staging in Patients With Intermediate or High-risk Prostate Cancer

NACompletedINTERVENTIONAL

Enrollment

177

Participants

Timeline

Start Date

January 9, 2013

Primary Completion Date

March 19, 2019

Study Completion Date

April 7, 2023

Conditions

Patient With Prostate Cancer

Interventions

PROCEDURE

standard lymphadenectomy

PROCEDURE

lymphadenectomy radio-isotope method

Trial Locations (1)

13354

Assistance Publique Hôpitaux de Marseille, Marseille

All Listed Sponsors

lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT02732392 - Validation of Radioisotope Guided Lymphadenectomy for Loco-regional Staging in Patients With Intermediate or High-risk Prostate Cancer | Biotech Hunter | Biotech Hunter